{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:43:36Z","timestamp":1785908616883,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2023-00259341"],"award-info":[{"award-number":["RS-2023-00259341"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2026-25483427"],"award-info":[{"award-number":["RS-2026-25483427"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000980","name":"Grains Research and Development Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.imlet.2026.107189","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T15:26:37Z","timestamp":1780154797000},"page":"107189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The vimentin-targeting monoclonal antibody hzVSF-V13 reduces TH17 cell numbers and osteoclastogenesis to attenuate rheumatoid arthritis progression"],"prefix":"10.1016","volume":"281","author":[{"given":"A Ram","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3406-4438","authenticated-orcid":false,"given":"Haeyoun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Yeong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Won","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Gyeong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5715-3989","authenticated-orcid":false,"given":"Mi-La","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.imlet.2026.107189_bib0001","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.imlet.2026.107189_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102392","article-title":"An overview of autoantibodies in rheumatoid arthritis","volume":"110","author":"van Delft","year":"2020","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0003","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.imlet.2026.107189_bib0004","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.yexcr.2007.03.040","article-title":"Novel functions of vimentin in cell adhesion, migration, and signaling","volume":"313","author":"Ivaska","year":"2007","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0005","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/ncb898","article-title":"Vimentin is secreted by activated macrophages","volume":"5","author":"Mor-Vaknin","year":"2003","journal-title":"Nat. Cell Biol."},{"issue":"4629","key":"10.1016\/j.imlet.2026.107189_bib0006","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/182186a0","article-title":"Content of citrulline and other amino-acids in a protein of hair follicles","volume":"182","author":"Rogers","year":"1958","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.imlet.2026.107189_bib0007","doi-asserted-by":"crossref","DOI":"10.1186\/ar3070","article-title":"Citrullinated vimentin as an important antigen in immune complexes from synovial fluid of rheumatoid arthritis patients with antibodies against citrullinated proteins","volume":"12","author":"Van Steendam","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.imlet.2026.107189_bib0008","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.autrev.2018.04.004","article-title":"Vimentin as antigenic target in autoimmunity: a comprehensive review","volume":"17","author":"Musaelyan","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"8","key":"10.1016\/j.imlet.2026.107189_bib0009","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2026.107189_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00018-022-04126-3","article-title":"Citrullination in the pathology of inflammatory and autoimmune disorders: recent advances and future perspectives","volume":"79","author":"Ciesielski","year":"2022","journal-title":"Cell Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.imlet.2026.107189_bib0011","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1172\/JCI60975","article-title":"Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin","volume":"122","author":"Harre","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.imlet.2026.107189_bib0012","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3389\/fimmu.2019.01483","article-title":"How autoantibodies regulate osteoclast induced bone loss in rheumatoid arthritis","volume":"10","author":"Steffen","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2026.107189_bib0013","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/ar1149","article-title":"Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin","volume":"6","author":"Vossenaar","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"6","key":"10.1016\/j.imlet.2026.107189_bib0014","first-page":"1002","article-title":"Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides","volume":"35","author":"Innala","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2026.107189_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.637829","article-title":"Role of the IL-23\/IL-17 pathway in rheumatic diseases: an overview","volume":"12","author":"Schinocca","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2026.107189_bib0016","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0017","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/art.25064","article-title":"Response of Th17 cells to a citrullinated arthritogenic aggrecan peptide in patients with rheumatoid arthritis","volume":"62","author":"von Delwig","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.imlet.2026.107189_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092321","article-title":"Combination treatment with the Vimentin-targeting antibody hzVSF and tenofovir suppresses woodchuck hepatitis virus infection in woodchucks","volume":"10","author":"Korolowicz","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.imlet.2026.107189_bib0019","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11112961","article-title":"Double-blind, randomized, placebo-controlled study on hzVSF-v13, a novel anti-Vimentin monoclonal antibody drug as add-on standard of care in the management of patients with moderate to severe COVID-19","volume":"11","author":"Prasenohadi","year":"2022","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.imlet.2026.107189_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07586","article-title":"Humanized virus-suppressing factor inhibits hepatitis B virus infection by targeting viral cell entry","volume":"7","author":"Miyakawa","year":"2021","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.imlet.2026.107189_bib0021","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.imlet.2026.107189_bib0022","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12291-012-0272-1","article-title":"Unique correlation between mutated citrullinated vimentine IgG autoantibodies and markers of systemic inflammation in rheumatoid arthritis patients","volume":"28","author":"Zahran","year":"2013","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.imlet.2026.107189_bib0023","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-070856","article-title":"Therapeutic advances in rheumatoid arthritis","volume":"384","author":"Brown","year":"2024","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.imlet.2026.107189_bib0024","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11926-008-0062-1","article-title":"Tumor necrosis factor inhibitors and infection complications","volume":"10","author":"Crawford","year":"2008","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-023-03111-w","article-title":"Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study","volume":"25","author":"Choi","year":"2023","journal-title":"Arthritis Res. Ther."},{"issue":"23","key":"10.1016\/j.imlet.2026.107189_bib0026","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.imlet.2026.107189_bib0027","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1002\/art.39313","article-title":"Release of active peptidyl arginine deiminases by neutrophils can explain production of extracellular citrullinated autoantigens in rheumatoid arthritis synovial fluid","volume":"67","author":"Spengler","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"178","key":"10.1016\/j.imlet.2026.107189_bib0028","doi-asserted-by":"crossref","first-page":"178ra40","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0030","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3343\/alm.2013.33.1.52","article-title":"Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis","volume":"33","author":"Kim","year":"2013","journal-title":"Ann. Lab. Med."},{"issue":"2","key":"10.1016\/j.imlet.2026.107189_bib0031","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/ard.2009.113092","article-title":"Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study","volume":"69","author":"Syversen","year":"2010","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.imlet.2026.107189_bib0032","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2026.107189_bib0033","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/728610","article-title":"The role of citrullinated protein antibodies in predicting erosive disease in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"2015","author":"Jilani","year":"2015","journal-title":"Int. J. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2026.107189_bib0034","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.imlet.2026.107189_bib0035","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5114\/reum.2020.102006","article-title":"Baricitinib for the treatment of rheumatoid arthritis","volume":"58","author":"Urits","year":"2020","journal-title":"Reumatologia"},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0036","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/BOR.0000000000000664","article-title":"Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages","volume":"32","author":"Coutant","year":"2020","journal-title":"Curr. Opin. Rheumatol."},{"issue":"11","key":"10.1016\/j.imlet.2026.107189_bib0037","doi-asserted-by":"crossref","first-page":"797","DOI":"10.7326\/0003-4819-146-11-200706050-00008","article-title":"Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis","volume":"146","author":"Nishimura","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.imlet.2026.107189_bib0038","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","article-title":"The influence of ACPA status and characteristics on the course of RA","volume":"8","author":"Willemze","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"1","key":"10.1016\/j.imlet.2026.107189_bib0039","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12016-007-8016-3","article-title":"Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis","volume":"34","author":"Poulsom","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2026.107189_bib0040","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","article-title":"Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies","volume":"73","author":"Kleyer","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.imlet.2026.107189_bib0041","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.imlet.2026.107189_bib0042","article-title":"Anti-citrullinated protein antibody generation, pathogenesis, clinical application, and prospects","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"issue":"10","key":"10.1016\/j.imlet.2026.107189_bib0043","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantapaa-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247826000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T04:43:48Z","timestamp":1785905028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247826000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0165247826000623"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107189","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The vimentin-targeting monoclonal antibody hzVSF-V13 reduces TH17 cell numbers and osteoclastogenesis to attenuate rheumatoid arthritis progression","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2026.107189","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Federation of Immunological Societies.","name":"copyright","label":"Copyright"}],"article-number":"107189"}}